Targeting HMGB-1 in Cancer and Immunomodulation with Vitamin D: Time to Focus and Research
Abstract
The failing immunity and chronic inflammatory disease have been acknowledged to contribute to the cancer development. HMGB-1 is a mediator of inflammation and has a paradoxical role in the pathogenesis of cancer.
Article Information
| Journal | SF Journal of Oncology Research |
| Article Type | Mini Review |
| Volume | 1 |
| Issue | 2 |